Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer

Lung Cancer

Volumn 85, Issue 3, 2014, Pages 366-372

  Yoda, Satoshi ^a   Soejima, Kenzo ^a   Hamamoto, Junko ^a   Yasuda, Hiroyuki ^a   Nakayama, Sohei ^a   Satomi, Ryosuke ^a   Terai, Hideki ^a   Ikemura, Shinnosuke ^a   Sato, Takashi ^a   Naoki, Katsuhiko ^a   Betsuyaku, Tomoko ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Claudin 1; Migration; MiR 375; Non small cell lung cancer; Survival; Target

Indexed keywords

CLAUDIN 1; MESSENGER RNA; MICRORNA 375; 3' UNTRANSLATED REGION; EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA; MIRN375 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CELL MIGRATION; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GENE INTERACTION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; INVESTIGATIVE PROCEDURES; LUCIFERASE ASSAY; LUNG ADENOCARCINOMA; LUNG CANCER CELL LINE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; WOUND HEALING; BINDING SITE; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; MUTATION; NUCLEOTIDE SEQUENCE; PROGNOSIS; RNA INTERFERENCE; TUMOR CELL LINE; VERY ELDERLY;

3' UNTRANSLATED REGIONS; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BINDING SITES; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CLAUDIN-1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MUTATION; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; RNA, MESSENGER;

EID: 84910681176     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2014.06.009     Document Type: Article

References (32)

1. Siegel R., Ward E., Brawley O., Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011, 61:212-236.
2. Liu L., Zhao E., Li C., Huang L., Xiao L., Cheng L., et al. TRIM28, a new molecular marker predicting metastasis and survival in early-stage non-small cell lung cancer. Cancer Epidemiol 2013, 37:71-78.
3. Hui A., How C., Ito E., Liu F.F. Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies. BMC Cancer 2011, 11:500.
4. Poy M.N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X., Macdonald P.E., et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432:226-230.
5. Kinoshita T., Nohata N., Yoshino H., Hanazawa T., Kikkawa N., Fujimura L., et al. Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma. Int J Oncol 2012, 40:185-193.
6. Nohata N., Hanazawa T., Kikkawa N., Mutallip M., Sakurai D., Fujimura L., et al. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). J Hum Genet 2011, 56:595-601.
7. Harris T., Jimenez L., Kawachi N., Fan J.B., Chen J., Belbin T., et al. Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas. Am J Pathol 2012, 180:917-928.
8. Kong K.L., Kwong D.L., Chan T.H., Law S.Y., Chen L., Li Y., et al. MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 2012, 61:33-42.
9. Tsukamoto Y., Nakada C., Noguchi T., Tanigawa M., Nguyen L.T., Uchida T., et al. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 2010, 70:2339-2349.
10. Bhatti I., Lee A., James V., Hall R.I., Lund J.N., Tufarelli C., et al. Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. J Gastrointest Surg 2011, 15:199-208.
11. Liu A.M., Poon R.T., Luk J.M. MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun 2010, 394:623-627.
12. He X.X., Chang Y., Meng F.Y., Wang M.Y., Xie Q.H., Tang F., et al. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 2012, 31:3357-3369.
13. Nishikawa E., Osada H., Okazaki Y., Arima C., Tomida S., Tatematsu Y., et al. Takahashi T. miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Res 2011, 71:6165-6173.
14. Hamamoto J., Soejima K., Yoda S., Naoki K., Nakayama S., Satomi R., et al. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma. Mol Med Rep 2013, 8:456-462.
15. Hewitt K.J., Agarwal R., Morin P.J. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 2006, 6:186.
16. Paschoud S., Bongiovanni M., Pache J.C., Citi S. Claudin-1 and claudin-5 expression patterns differentiate lung squamous cell carcinomas from adenocarcinomas. Mod Pathol 2007, 20:947-954.
17. Liu Y., Sun W., Zhang K., Zheng H., Ma Y., Lin D., et al. Identification of genes differentially expressed in human primary lung squamous cell carcinoma. Lung Cancer 2007, 56:307-317.
18. Jung J.H., Jung C.K., Choi H.J., Jun K.H., Yoo J., Kang S.J., et al. Diagnostic utility of expression of claudins in non-small cell lung cancer: different expression profiles in squamous cell carcinomas and adenocarcinomas. Pathol Res Pract 2009, 205:409-416.
19. Kinoshita T., Hanazawa T., Nohata N., Okamoto Y., Seki N. The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways. J Hum Genet 2012, 57:556-563.
20. Terai H., Soejima K., Yasuda H., Nakayama S., Hamamoto J., Arai D., et al. Activation of the FGF2-FGFR1 autocrine pathway: a novel mechanism of acquired resistance to gefitinib in NSCLC. Mol Cancer Res 2013, 11:759-767.
21. Wittekind C., Compton C.C., Greene F.L., Sobin L.H. TNM residual tumor classification revisited. Cancer 2002, 94:2511-2516.
22. Ohgino K., Soejima K., Yasuda H., Hayashi Y., Hamamoto J., Naoki K., et al. Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer. Lung Cancer 2013, 83:90-96.
23. Kawada I., Soejima K., Watanabe H., Nakachi I., Yasuda H., Naoki K., et al. An alternative method for screening EGFR mutation using RFLP in non-small cell lung cancer patients. J Thorac Oncol 2008, 3:1096-1103.
24. Liang C.C., Park A.Y., Guan J.L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007, 2:329-333.
25. Berghmans T., Ameye L., Willems L., Paesmans M., Mascaux C., Lafitte J.J., et al. Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study. Lung Cancer 2013, 82:340-345.
26. Chao Y.C., Pan S.H., Yang S.C., Yu S.L., Che T.F., Lin C.W., et al. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma. Am J Respir Crit Care Med 2009, 179:123-133.
27. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008, 105:10513-10518.
28. Nguyen H.C., Xie W., Yang M., Hsieh C.L., Drouin S., Lee G.S., et al. Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer. Prostate 2013, 73:346-354.
29. Bryant R.J., Pawlowski T., Catto J.W., Marsden G., Vessella R.L., Rhees B., et al. Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer 2012, 106:768-774.
30. Cheng H.H., Mitchell P.S., Kroh E.M., Dowell A.E., Chéry L., Siddiqui J., et al. Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia. PLOS ONE 2013, 8:e69239.
31. Selth L.A., Townley S., Gillis J.L., Ochnik A.M., Murti K., Macfarlane R.J., et al. Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease. Int J Cancer 2012, 131:652-661.
32. Li Y., Jiang Q., Xia N., Yang H., Hu C. Decreased expression of microRNA-375 in nonsmall cell lung cancer and its clinical significance. J Int Med Res 2012, 40:1662-1669.